EGFR and non-small cell lung carcinoma: Recently, our study found that, comparing with mesenchymal phenotype, epithelial phenotype was associated with a significantly higher ORR, longer PFS and OS after EGFR-TKIs therapy in advanced NSCLC patients with EGFR-WT [38].